117 related articles for article (PubMed ID: 2575174)
1. Doxazosin, a new alpha-1-antagonist drug, controls hypertension without causing airways obstruction in asthma and COPD.
Biernacki W; Flenley DC
J Hum Hypertens; 1989 Dec; 3(6):419-25. PubMed ID: 2575174
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of the efficacy and safety of doxazosin in the treatment of hypertension associated with renal insufficiency.
Anderton JL; Notghi A
J Hum Hypertens; 1990 Oct; 4 Suppl 3():52-7. PubMed ID: 2148196
[TBL] [Abstract][Full Text] [Related]
4. [Comparative effects of doxazosin and enalapril in patients with arterial hypertension and exercise-induced acute myocardial ischemia].
Passarelli P; Galiè N; Limonetti P; Branzi A; Magnani B
Cardiologia; 1991 Oct; 36(10):777-83. PubMed ID: 1686851
[TBL] [Abstract][Full Text] [Related]
5. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
J Hum Hypertens; 1992 Jun; 6(3):181-4. PubMed ID: 1352827
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
7. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
8. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy.
Ikeda T; Gomi T; Shibuya Y; Shinozaki S; Suzuki Y; Matsuda N
Hypertens Res; 2007 Nov; 30(11):1097-105. PubMed ID: 18250559
[TBL] [Abstract][Full Text] [Related]
9. The role of alpha 1-blockers in combination therapy for hypertension.
Zusman RM
Int J Clin Pract; 2000; 54(1):36-40. PubMed ID: 10750258
[TBL] [Abstract][Full Text] [Related]
10. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
Kamoi K; Ikarashi T
Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of doxazosin and atenolol on smoking-induced peripheral vasoconstriction in hypertensive habitual smokers.
Lecerof H; Bornmyr S; Lilja B; De Pedis G; Hulthén UL
J Hypertens Suppl; 1990 Sep; 8(5):S29-33. PubMed ID: 1981074
[TBL] [Abstract][Full Text] [Related]
12. Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practice.
Chung BH; Hong SJ; Lee MS
Int J Urol; 2005 Feb; 12(2):159-65. PubMed ID: 15733110
[TBL] [Abstract][Full Text] [Related]
13. [Doxazosin for the treatment of arterial hypertension].
Mozzato MG; Semplicini A; Serena L; Valle R; Casolino P; Buzzaccarini F; Rubino N; Giusto M; Pessina AC
Cardiologia; 1990 Nov; 35(11):931-6. PubMed ID: 2151571
[TBL] [Abstract][Full Text] [Related]
14. [Randomized, comparative study to evaluate efficacy and safety of doxazosin versus nitrendipine in the treatment of mild to moderate hypertension].
Sanz Guajardo D; Espejo Martínez J
An Med Interna; 1997 Jan; 14(1):15-9. PubMed ID: 9091027
[TBL] [Abstract][Full Text] [Related]
15. Chronic alpha-1-adrenergic blockade increases sympathoneural but not adrenomedullary activity in patients with essential hypertension.
Jacobs MC; Lenders JW; Willemsen JJ; Thien T
J Hypertens; 1995 Dec; 13(12 Pt 2):1837-41. PubMed ID: 8903663
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition.
Groppelli A; Omboni S; Parati G; Mancia G
J Hypertens Suppl; 1990 Sep; 8(5):S35-40. PubMed ID: 1981075
[TBL] [Abstract][Full Text] [Related]
17. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
Yasuda G; Hasegawa K; Kuji T; Ogawa N; Shimura G; Umemura S; Tochikubo O
Diabet Med; 2005 Oct; 22(10):1394-400. PubMed ID: 16176202
[TBL] [Abstract][Full Text] [Related]
18. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension.
Ceral J; Solar M
Blood Press; 2009; 18(1-2):74-7. PubMed ID: 19353415
[TBL] [Abstract][Full Text] [Related]
19. An alpha-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study.
Kario K; Matsui Y; Shibasaki S; Eguchi K; Ishikawa J; Hoshide S; Ishikawa S; Kabutoya T; Schwartz JE; Pickering TG; Shimada K;
J Hypertens; 2008 Jun; 26(6):1257-65. PubMed ID: 18475166
[TBL] [Abstract][Full Text] [Related]
20. [One-year controlled therapy with doxazosin in patients with pulmonary hypertension due to chronic obstructive pulmonary disease].
Ludwik B; Lewczuk J; Piszko P; Nowak M; Wrabec K
Pol Merkur Lekarski; 2006 May; 20(119):527-30. PubMed ID: 16875154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
